>> Photographs

>> 2016 CAN-PAT report

>> Outline
>> Guest speakers
>> Symposium speakers
>> Case submission









2017 CRS Meeting Planning Committee

Netan Choudhry, MD, FRCSC, DABO

Netan Choudhry, MD, FRCSC, DABO

Director of Vitreoretinal Surgery
Herzig Eye Institute
Toronto, Ontario

Dr. Choudhry grew up in Toronto, Ontario and he completed his medical degree at Georgetown University in Washington, DC. He subsequently completed his residency in ophthalmology at the University of Pennsylvania Scheie Eye Institute in Philadelphia. He then went on to complete a two-year fellowship in vitreoretinal surgery at the Massachusetts Eye & Ear Infirmary Harvard Medical School. Dr. Choudhry is board certified in Canada and the United States.

He is active in clinical research with an emphasis in retinal imaging and has published in the New England Journal of Medicine, The Lancet, and the American Journal of Ophthalmology, among others.

Dr. Choudhry is on the board of directors at the American Society of Retina Specialists and is presently the program chair for the Canadian Retina Society. He also works as the retina section editor of the Canadian Journal of Ophthalmology and serves as a faculty member at the Massachusetts Eye & Ear Harvard Medical School Annual Vitrectomy Course.

Dr. Choudhry enjoys teaching students and resident/fellow physicians and is exploring new approaches to education. He has worked on the development of remote learning programs for teaching ophthalmology in underserved areas and has actively participated in webinar lectures. He has lectured both nationally in Canada and globally.

As a vitreoretinal surgeon, Dr. Choudhry specializes in diseases of the retina and vitreous including: diabetic retinopathy, age-related macular degeneration, retina vein occlusion, retinal detachment among many others. He is also certified in femtosecond laser-assisted cataract surgery.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

  1. Alcon
  2. Bayer
  3. Novartis
  4. Optos
  5. Topcon

Amin Kherani, MD

Amin Kherani, MD, FRCSC

Dr. Kherani is an ophthalmologist, vitreoretinal specialist, and associate clinical professor at the University of Calgary. He has been a strong program advocate locally helping shape academic growth within the residency program as the inaugural program director; he also co-directs the retinal fellowship program in Calgary. He has been instrumental in the growth and development of the conjoint uveitis-rheumatology program, a unique collaboration of specialists to help this complex group of patients. He is a cofounder of both Calgary Retina Consultants and Southern Alberta Eye Centre, a state-of-the-art integrated diagnostic, clinical and outpatient surgery facility.

In addition to his busy practice, Dr. Kherani is very active as a surgical educator and lecturer and maintains a substantial academic and research program, making significant contributions to the medical literature. He volunteers as the president of the University Eye Foundation, a local charity that support ophthalmology program development. Recently, he was appointed president of the Canadian Retina Society.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

  1. Bayer
  2. Abbott
  3. Allergan
  4. Alcon
  5. Roche-Genentech
  6. Novartis
  7. Amgen
  8. Ontario genomics,
  9. University of British Columbia
  10. Bausch & Lomb

Deepa Yoganathan, MD, FRCSC, DABO

Deepa Yoganathan, MD, FRCSC, DABO

Dr. Yoganathan was born and raised in Montreal and completed a bachelor of science degree in physiology at McGill University. She graduated from medical school at Albany Medical College and residency at the North Shore - Long Island Jewish Health System in New York. In 2009 she graduated from a two-year vitreoretinal fellowship at the University of Toronto, St Michael's Hospital.

Dr. Yoganathan has been practising in both Toronto and Buffalo for five years. She was the director of the Retina Service at the Ross Eye Institute and assistant professor at the University at Buffalo. She was awarded Teacher of the Year in her first year of practice. Dr. Yoganathan has since completed the Royal College of Physicians and Surgeons of Canada's Educators Faculty Development Program to improve resident education.

Dr. Yoganathan has been invited to lecture at the Cleveland Ophthalmological Society, Case Western University, Sri Lankan Ophthalmology Congress, Vit-Buckle Society, and the National Medical Association three years in a row. She initiated a visiting professor series and organized several annual symposia at the University at Buffalo.

Dr. Yoganathan was the principal site investigator for the DRCR.net (diabetic retinopathy clinical research network) at the Ross Eye Institute and continues to be a DRCR investigator at Toronto Retina Institute. She is also the principal study investigator for investigator-initiated trials, both funded and pending funding. She has presented her research numerous times at the ASRS, AAO, ARVO, and the Canadian Ophthalmological Society. Dr. Yoganathan will be graduating with a master's of science degree in health research methodology from McMaster University in 2016.

Dr. Yoganathan has a special interest in traumatic retinal detachments and diabetic tractional detachments. Her area of research is diabetic retinopathy, diabetic macular edema, and trauma. She is also interested in volunteering her time, and has completed two cataract missions to the Philippines and performed vitreoretinal surgery at Jaffna Teaching Hospital in Sri Lanka.

Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization.

  1. Alcon
  2. Allergan
  3. Bausch and Lomb
  4. Bayer
  5. Novartis